All News

May
26
2020

AcouSort Annual Report 2019

Today 26 May 2020, AcouSort is releasing its Annual Report 2019 (in Swedish). Please find the full report including auditor statement (in Swedish) here: AcouSort Årsredovisning 2019

Read More
May
26
2020

AcouSort recieves top rating from Eurostars for project on stem cells for regenerative therapy

The project Blue4Therapy, where AcouSort is a co-applicant, is ranked number 17 among 449 candidates applying for Eurostars funding. If the project is funded, AcouSort will be able to accelerate

Read More
May
20
2020

AcouSort presents updated strategy for 2020-2030

The last 12 months have been the most eventful and exciting year in the history of AcouSort. The company has experienced a rapidly growing interest for its unique technology. Based

Read More
May
13
2020

AcouSort secures working capital for 2020

AcouSort has obtained loan guarantees of just over SEK 3 million through a consortium consisting of the company’s management, board and founders. The loan guarantee aims to make AcouSort financially

Read More
May
12
2020

Notice of AGM

AcouSort welcomes its share holders to the Annual General Meeting on the 9th of June 2020. The meeting will be held at Medicon Village and starts at 9.00.   Find the

Read More
May
12
2020

Delivery of AcouWash to Umeå University

Earlier this year, AcouSort reported having recieved an order from Umeå University regarding a modified AcouWash system. The system has been upgraded to enable separation of circulating tumor cells (CTC)

Read More
May
11
2020

Analyst Group initiating coverage on AcouSort

Read the full press release in Swedish, here.

Read More
Apr
17
2020

Patent approved for new method to separate cells with sound

AcouSort’s patent application for a new method of separating cells with sound has been approved. The new method makes it possible to separate cells that are similar in size and weight.

Read More
Apr
7
2020

Interview with CEO

“The market for consumable and semi-consumable blood-plasma separation modules is estimated to grow significantly in the coming years as blood plasma is required for numerous blood-based assays used in health

Read More
Mar
26
2020

Status update: Still great interest in the AcouSort technology despite canceled conferences

AcouSort publishes an update on how the company is affected by the current situation. AcouSort is experiencing continuedly growing interest in the company’s products. Although the world situation has changed,

Read More